However, Berhane et al. [74] found that statistically significant increased risk of prostate cancer was observed on individuals that posses His/His genotype of XPG (OR = 2.53, 95% CI = 0.99–6.56, P = 0.031). This evidence concerns the gene ERCC5 and prostate cancer.